Product Information
DIFLUNISAL 500 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $1.0427 per EA under NDC 00093922206. Its NADAC has been published 262 times since Aug 18, 2021.
FDA first approved this application on Jul 31, 1992. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093922206
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DIFLUNISALApproval Type
Generic (ANDA)
FDA Application
ANDA073673FDA Approved
7/31/1992
TE Code
AB
On Market Since
6/30/2021
Pharmacological Classes
Price Statistics
The NADAC for DIFLUNISAL 500 MG TABLET has been published 262 times since Aug 18, 2021, and over the history we have for it it has declined 25.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0427 per EA |
|---|---|
| All-time high | $1.3963 (Sep 15, 2021) |
| All-time low | $0.8327 (Dec 21, 2022) |
| 52-week high | $1.1995 |
| 52-week low | $1.0380 |
| Median price | $1.0520 |
| Average price | $1.0554 |
| Largest weekly change | -29.8% (Dec 21, 2022) |
| Weeks tracked | 262 |
| Tracking since | Aug 18, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of DIFLUNISAL 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DIFLUNISAL 500 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $1.0427 per EA (NDC 00093922206), effective Aug 19, 2026.
How has the price of DIFLUNISAL 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for DIFLUNISAL 500 MG TABLET has declined 25.3%. It has been tracked across 262 weekly CMS publications since Aug 18, 2021.
What are the highest and lowest recorded NADAC prices for DIFLUNISAL 500 MG TABLET?
Since Aug 18, 2021, the NADAC for DIFLUNISAL 500 MG TABLET has ranged from a low of $0.8327 (Dec 21, 2022) to a high of $1.3963 (Sep 15, 2021), with a median of $1.0520 per EA.
Are there cheaper alternatives to DIFLUNISAL 500 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as DIFLUNISAL 500 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures DIFLUNISAL 500 MG TABLET?
DIFLUNISAL 500 MG TABLET (NDC 00093922206) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.